Search
A new study from researchers at MSK and Weill Cornell Medicine provides fresh insights about how cancers evolve when they metastasize — insights that could aid in developing strategies to improve the effectiveness of treatment.
For clinical research stakeholders, implementing and scaling electronic source date (eSource) is a priority. With participation from MSK, a number of Society of Clinical Data Management (SCDM) working groups have collaborated on a paper outlining consensus recommendations on eSource best practices.
MSK patients will remain in-network to continue receiving world-class cancer care.
Memorial Sloan Kettering Cancer Center (MSK) is pleased to announce TIME has named two MSK physician-scientists, Andrea Cercek, MD, and Vinod Balachandran, MD, to the 2025 TIME100 Health, a list of the 100 most influential individuals in health.
Learn about how MSK’s new Lobular Breast Cancer Program is working to improve outcomes for people with invasive lobular breast cancer and other types of LBC.
Radiation is a feasible option for patients with squamous cell carcinoma of the anterior nasal cavity mucosa who refuse rhinectomy, according to our recent research.
Hear from cervical cancer survivor Susan Shaw about how she joined the Empire Dragon Boat Team three years ago and is in the best shape of her life.
Our recent prospective study data provides support for the incorporation of plasma next-generation sequencing (NGS) assays into lung cancer practice guidelines.
Researchers at Memorial Sloan Kettering (MSK) report that firefighters at the World Trade Center (WTC) scene in September 2001 were nearly twice as likely as the general population to have a multiple myeloma precursor condition called monoclonal gammopathy of undetermined significance (MGUS). This new research was published online today in JAMA Oncology.